BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu XY, Liu F. Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy. J Dig Dis 2017;18:195-202. [PMID: 28294543 DOI: 10.1111/1751-2980.12466] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Au-doung PLW, Chan RH, Wu WKK, Li Q. Gut Microbiota Modulation: Probiotics and Prebiotics in GI Cancer. Microbiome in Gastrointestinal Cancer 2023. [DOI: 10.1007/978-981-19-4492-5_14] [Reference Citation Analysis]
2 Noor S, Ali S, Riaz S, Sardar I, Farooq MA, Sajjad A. Chemopreventive role of probiotics against cancer: a comprehensive mechanistic review. Mol Biol Rep 2023;50:799-814. [PMID: 36324027 DOI: 10.1007/s11033-022-08023-7] [Reference Citation Analysis]
3 Telaku S, Telaku M, Behluli E, Isjanovski V, Alidema F. Impact of Lactobacillus Reuteri and Three Other Probiotics in Helicobacter Pylori Eradication. Open Access Maced J Med Sci 2022;10:2215-2219. [DOI: 10.3889/oamjms.2022.10733] [Reference Citation Analysis]
4 Kharwar A, Bazaz MR, Dandekar MP. Quantitative and qualitative characterization of commercially available oral suspension of probiotic products containing Bacillus Clausii spores. BMC Microbiol 2022;22. [DOI: 10.1186/s12866-022-02631-w] [Reference Citation Analysis]
5 Andreev DN, Maev IV, Bordin DS, Lyamina SV, Dicheva DT, Fomenko AK, Bagdasarian AS. Effectiveness of Rebamipide as a part of the <i>Helicobacter pylori</i> eradication therapy in Russia: a meta-analysis of controlled trials. Consilium Medicum 2022;24:333-338. [DOI: 10.26442/20751753.2022.5.201863] [Reference Citation Analysis]
6 Meyer-déru L, David G, Auvergne R. Chitosan chemistry review for living organisms encapsulation. Carbohydrate Polymers 2022. [DOI: 10.1016/j.carbpol.2022.119877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li X, Zhu L, Wang X, Li J, Tang B. Evaluation of IR Biotyper for Lactiplantibacillus plantarum Typing and Its Application Potential in Probiotic Preliminary Screening. Front Microbiol 2022;13:823120. [DOI: 10.3389/fmicb.2022.823120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Bai X, Zhu M, He Y, Wang T, Tian D, Shu J. The impacts of probiotics in eradication therapy of Helicobacter pylori. Arch Microbiol 2022;204:692. [PMID: 36344628 DOI: 10.1007/s00203-022-03314-w] [Reference Citation Analysis]
9 Acosta-Rodríguez-Bueno CP, Abreu Y Abreu AT, Guarner F, Guno MJV, Pehlivanoğlu E, Perez M 3rd. Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review. Adv Ther 2022;39:4854-74. [PMID: 36018495 DOI: 10.1007/s12325-022-02285-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Park JM, Han YM, Oh JY, Lee DY, Choi SH, Kim SJ, Hahm KB. Fermented kimchi rejuvenated precancerous atrophic gastritis via mitigating Helicobacter pylori-associated endoplasmic reticulum and oxidative stress. J Clin Biochem Nutr 2021;69:158-70. [PMID: 34616108 DOI: 10.3164/jcbn.20-180] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Mladenova I. Clinical Relevance of Helicobacter pylori Infection. J Clin Med 2021;10:3473. [PMID: 34441769 DOI: 10.3390/jcm10163473] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
12 Coker OO, Yu J. Microbiome in Human Gastrointestinal Cancers. Physiology in Health and Disease 2021. [DOI: 10.1007/978-3-030-67951-4_2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Debnath N, Kumar Yadav A, Tyagi A. Probiotic Microorganism: A Promising and Innovative Tool for Cancer Prevention and Therapy. Advances in Probiotics 2021. [DOI: 10.1016/b978-0-12-822909-5.00012-5] [Reference Citation Analysis]
14 Tasdemir SS, Sanlier N. An insight into the anticancer effects of fermented foods: A review. Journal of Functional Foods 2020;75:104281. [DOI: 10.1016/j.jff.2020.104281] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
15 Khan AA, Nema V, Khan Z. Current status of probiotics for prevention and management of gastrointestinal cancers. Expert Opin Biol Ther 2021;21:413-22. [PMID: 33034210 DOI: 10.1080/14712598.2021.1828858] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
16 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
17 Mahmoud M, Abdallah NA, El-Shafei K, Tawfik NF, El-Sayed HS. Survivability of alginate-microencapsulated Lactobacillus plantarum during storage, simulated food processing and gastrointestinal conditions. Heliyon 2020;6:e03541. [PMID: 32190759 DOI: 10.1016/j.heliyon.2020.e03541] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
18 de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, Neves PHM, de Melo FF. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol 2019; 25(37): 5578-5589 [PMID: 31602159 DOI: 10.3748/wjg.v25.i37.5578] [Cited by in CrossRef: 82] [Cited by in F6Publishing: 86] [Article Influence: 20.5] [Reference Citation Analysis]
19 Andreev DN, Maev IV, Dicheva DT. Efficiency of the Inclusion of Rebamipide in the Eradication Therapy for Helicobacter pylori Infection: Meta-Analysis of Randomized Controlled Studies. J Clin Med 2019;8:E1498. [PMID: 31546909 DOI: 10.3390/jcm8091498] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
20 Buckley M, Lacey S, Doolan A, Goodbody E, Seamans K. The effect of Lactobacillus reuteri supplementation in Helicobacter pylori infection: a placebo-controlled, single-blind study. BMC Nutr 2018;4:48. [PMID: 32153909 DOI: 10.1186/s40795-018-0257-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
21 Akdeniz V, Akalın AS, Özer E. ROLE OF PROBIOTICS IN Helicobacter pylori INFECTION. GIDA / THE JOURNAL OF FOOD 2018. [DOI: 10.15237/gida.gd18062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Pérez-arellano E, Rodriguez-garcia MI, Galera Rodenas AB, de la Morena-madrigal E. Eradication of Helicobacter pylori infection with a new bismuth-based quadruple therapy in clinical practice. Gastroenterología y Hepatología (English Edition) 2018;41:145-152. [DOI: 10.1016/j.gastre.2018.03.004] [Reference Citation Analysis]
23 Pérez-arellano E, Rodriguez-garcia MI, Galera Rodenas AB, de la Morena-madrigal E. Erradicación de la infección por Helicobacter pylori con una nueva terapia cuádruple basada en bismuto en la práctica clínica. Gastroenterología y Hepatología 2018;41:145-52. [DOI: 10.1016/j.gastrohep.2017.08.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]